{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:44:28Z","timestamp":1780544668042,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75116-7","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T10:49:45Z","timestamp":1740566985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["New nanomanufacturing strategy through bioinspired design, for promising treatment of Parkinson\u2019s disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Aliaa A.","family":"Razzak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3816-2876","authenticated-orcid":false,"given":"Zahraa S.","family":"Al-Garawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2191-0500","authenticated-orcid":false,"given":"Adawiya J.","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1005-4032","authenticated-orcid":false,"given":"F. A. A. N Bahaa","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"issue":"1","key":"75116_CR1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12951-021-00855-y","volume":"19","author":"A -Smith","year":"2021","unstructured":"-Smith, A. & Roberts, L. Exploring the use of nanocarriers for effective drug delivery in neurodegenerative diseases. J. Nanobiotechnol. 19 (1), 112 (2021).","journal-title":"J. Nanobiotechnol."},{"key":"75116_CR2","first-page":"23","volume":"152","author":"K -Johnson","year":"2020","unstructured":"-Johnson, K. & Patel, M. Nanotechnology in neurodegenerative disease: focus on Parkinson\u2019s. Neurosci. Res. 152, 23\u201334 (2020).","journal-title":"Neurosci. Res."},{"key":"75116_CR3","first-page":"55","volume":"142","author":"Y -Lee","year":"2019","unstructured":"-Lee, Y. & Kim, H. Advances in BBB crossing nanocarrier systems for drug delivery. Eur. J. Pharm. Biopharm. 142, 55\u201370 (2019).","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"75116_CR4","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1038\/s41598-023-30221-x","volume":"13","author":"R -Al-Obaidy","year":"2023","unstructured":"-Al-Obaidy, R., Haider, A. J., Al-Musawi, S. & Arsad, N. Targeted delivery of paclitaxel drug using polymer-coated magnetic nanoparticles for fibrosarcoma therapy: in vitro and in vivo studies. Sci. Rep. 13 (1), 3180 (2023).","journal-title":"Sci. Rep."},{"issue":"6","key":"75116_CR5","first-page":"1823","volume":"29","author":"S -Gupta","year":"2018","unstructured":"-Gupta, S. & Kumar, P. Albumin-based nanoparticles in cancer therapy and imaging. Bio Conjugate Chem. 29 (6), 1823\u20131835 (2018).","journal-title":"Bio Conjugate Chem."},{"key":"75116_CR6","doi-asserted-by":"crossref","unstructured":"-VeleshKolaei, M. R. H., Gill, P., Rafati, A. & Adiani, M. Bioinformatical Prediction of G-quadruplex Aptamer for detection of a Ligand in practice. J. Appl. Sci. Nanatechnol., 3(4). (2023).","DOI":"10.53293\/jasn.2023.7058.1234"},{"issue":"3","key":"75116_CR7","first-page":"865","volume":"110","author":"J -Davis","year":"2022","unstructured":"-Davis, J. & Young, R. Chitosan-based systems for neuroprotective drug delivery: a review. J. Biomedical Mater. Res. Part. A. 110 (3), 865\u2013878 (2022).","journal-title":"J. Biomedical Mater. Res. Part. A"},{"issue":"2","key":"75116_CR8","first-page":"5307","volume":"20","author":"AJM -AL-OGAIDI","year":"2020","unstructured":"-AL-OGAIDI, A. J. M., Hamid, D. M. & Mohammed, A. A. R. Ultra Higher Assessment of CEA by using Sensing Technology. Biochem. Cell. Archives. 20 (2), 5307\u20135309 (2020).","journal-title":"Biochem. Cell. Archives"},{"issue":"3","key":"75116_CR9","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s11595-012-0485-4","volume":"27","author":"Q -Sun","year":"2012","unstructured":"-Sun, Q. et al. Preparation and characterization of chitosan microsphere loading bovine serum albumin. J. Wuhan Univ. Technology-Mater Sci. Ed. 27 (3), 459\u2013464 (2012).","journal-title":"J. Wuhan Univ. Technology-Mater Sci. Ed."},{"issue":"4","key":"75116_CR10","first-page":"33","volume":"3","author":"NB -Basosila","year":"2023","unstructured":"-Basosila, N. B. et al. Biogenic synthesis, Spectroscopic characterization and bioactivity of Cymbopogon citratus Derived Silver nanoparticles. J. Appl. Sci. Nanatechnol. 3 (4), 33\u201341 (2023).","journal-title":"J. Appl. Sci. Nanatechnol."},{"issue":"1","key":"75116_CR11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40263-019-00689-1","volume":"34","author":"F -Robinson","year":"2020","unstructured":"-Robinson, F. & Lee, V. Nanomedicine for CNS disorders: opportunities and challenges. CNS Drugs. 34 (1), 9\u201323 (2020).","journal-title":"CNS Drugs"},{"issue":"6","key":"75116_CR12","first-page":"601","volume":"16","author":"L -Williams","year":"2019","unstructured":"-Williams, L. & Brown, T. Nanotechnology in neurotherapeutics: a review. Expert Opin. Drug Deliv. 16 (6), 601\u2013613 (2019).","journal-title":"Expert Opin. Drug Deliv."},{"key":"75116_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cocis.2020.02.001","volume":"48","author":"Z -Khan","year":"2020","unstructured":"-Khan, Z. & Singh, T. Overcoming the blood-brain barrier: nanoparticle-based therapies for neurological diseases. Curr. Opin. Colloid Interface Sci. 48, 1\u201315 (2020).","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"75116_CR14","doi-asserted-by":"crossref","unstructured":"-Edan, M. S. et al. Effect of Silver Nanoparticles Synthesized by Pulsed Laser Ablation in Liquid on the Hematological, Hepatic, and Renal Functions of Albino rats (Iraqi Journal of Science, 2023).","DOI":"10.24996\/ijs.2023.64.12.13"},{"issue":"4","key":"75116_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s11051-021-05218-0","volume":"23","author":"E -Ortega","year":"2021","unstructured":"-Ortega, E. et al. Lipid nanoparticles for the transport of drugs like dopamine through the blood-brain barrier. J. Nanopart. Res. 23 (4), 106 (2021).","journal-title":"J. Nanopart. Res."},{"key":"75116_CR16","first-page":"57","volume":"285","author":"M -Green","year":"2018","unstructured":"-Green, M. & Thompson, B. Albumin as a versatile platform for drug delivery: opportunities and challenges. J. Controlled Release. 285, 57\u201370 (2018).","journal-title":"J. Controlled Release"},{"key":"75116_CR17","doi-asserted-by":"crossref","unstructured":"-Attallah, A. H., Abdulwahid, F. S., Ali, Y. A. & Haider, A. J. Enhanced Characteristics of Iron Oxide Nanoparticles for Efficient Pollutant Degradation via Pulsed Laser Ablation in Liquid1\u201314 (Plasmonics, 2024).","DOI":"10.1007\/s11468-024-02192-w"},{"issue":"3","key":"75116_CR18","first-page":"1","volume":"1","author":"AA -Al-Jubori","year":"2021","unstructured":"-Al-Jubori, A. A., Sulaiman, G. M. & Tawfeeq, A. T. Antioxidant activities of Resveratrol Loaded Poloxamer 407: an in Vitro and in vivo study. J. Appl. Sci. Nanatechnol. 1 (3), 1\u201312 (2021).","journal-title":"J. Appl. Sci. Nanatechnol."},{"issue":"1","key":"75116_CR19","doi-asserted-by":"publisher","first-page":"015001","DOI":"10.1088\/2043-6262\/aca606","volume":"14","author":"FS -Abdulwahid","year":"2023","unstructured":"-Abdulwahid, F. S., Haider, A. J. & Al-Musawi, S. Folate decorated dextran-coated magnetic nanoparticles for targeted delivery of ellipticine in cervical cancer cells. Adv. Nat. Sci. NanoSci. NanoTechnol. 14 (1), 015001 (2023).","journal-title":"Adv. Nat. Sci. NanoSci. NanoTechnol."},{"issue":"1","key":"75116_CR20","first-page":"100","volume":"15","author":"S -Patel","year":"2019","unstructured":"-Patel, S. & Johnson, J. Targeted nanoparticle systems for Parkinson\u2019s disease therapy. Nanomed. Nanotechnol. Biol. Med. 15 (1), 100\u2013104 (2019).","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"4","key":"75116_CR21","first-page":"1735","volume":"58","author":"D -Robinson","year":"2021","unstructured":"-Robinson, D. & Lee, V. Nanotechnology in the treatment of neurodegenerative disorders: from concept to application. Mol. Neurobiol. 58 (4), 1735\u20131750 (2021).","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"75116_CR22","first-page":"345","volume":"19","author":"J -Williams","year":"2022","unstructured":"-Williams, J. & Brown, T. Innovative approaches in nanomedicine for neurodegenerative disorders. Neurotherapeutics. 19 (2), 345\u2013359 (2022).","journal-title":"Neurotherapeutics"},{"issue":"11","key":"75116_CR23","doi-asserted-by":"publisher","first-page":"2230007","DOI":"10.1142\/S1793292022300079","volume":"17","author":"FS -Abdulwahid","year":"2022","unstructured":"-Abdulwahid, F. S., Haider, A. J. & Al-Musawi, S. Iron oxide nanoparticles (IONPs): synthesis, surface functionalization, and targeting drug delivery strategies: mini-review. Nano. 17 (11), 2230007 (2022).","journal-title":"Nano"},{"issue":"10","key":"75116_CR24","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3390\/pharmaceutics13101686","volume":"13","author":"N -Aibani","year":"2021","unstructured":"-Aibani, N., Rai, R., Patel, P., Cuddihy, G. & Wasan, E. K. Chitosan nanoparticles at the biological interface: implications for drug delivery. Pharmaceutics. 13 (10), 1686 (2021).","journal-title":"Pharmaceutics"},{"key":"75116_CR25","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s00216-011-4962-y","volume":"400","author":"E -De Giglio","year":"2011","unstructured":"-De Giglio, E., Trapani, A., Cafagna, D., Sabbatini, L. & Cometa, S. Dopamine-loaded chitosan nanoparticles: formulation and analytical characterization. Anal. Bioanal. Chem. 400, 1997\u20132002 (2011).","journal-title":"Anal. Bioanal. Chem."},{"issue":"4","key":"75116_CR26","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s11468-023-01852-7","volume":"18","author":"AH -Attallah","year":"2023","unstructured":"-Attallah, A. H., Abdulwahid, F. S., Ali, Y. A. & Haider, A. J. Effect of liquid and laser parameters on fabrication of nanoparticles via pulsed laser ablation in liquid with their applications: a review. Plasmonics. 18 (4), 1307\u20131323 (2023).","journal-title":"Plasmonics"},{"issue":"1","key":"75116_CR27","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1080\/10717544.2017.1359862","volume":"24","author":"E -Barcia","year":"2017","unstructured":"-Barcia, E. et al. Nanotechnology-based drug delivery of ropinirole for Parkinson\u2019s disease. Drug Deliv. 24 (1), 1112\u20131123 (2017).","journal-title":"Drug Deliv."},{"key":"75116_CR28","doi-asserted-by":"crossref","unstructured":"-Katas, H., Hussain, Z. & Awang, S. A. Bovine serum albumin-loaded chitosan\/dextran nanoparticles: preparation and evaluation of ex vivo colloidal stability in serum. Journal of Nanomaterials, 2013, 1\u20139. (2013).","DOI":"10.1155\/2013\/536291"},{"key":"75116_CR29","doi-asserted-by":"crossref","unstructured":"-Bronze-Uhle, E. S., Costa, B. C., Ximenes, V. F. & Lisboa-Filho, P. N. Synthetic nanoparticles of bovine serum albumin with entrapped salicylic acid. Nanatechnol. Sci. Appl., 11\u201321. (2016).","DOI":"10.2147\/NSA.S117018"},{"key":"75116_CR30","doi-asserted-by":"publisher","first-page":"125501","DOI":"10.1016\/j.colsurfa.2020.125501","volume":"608","author":"R -Solanki","year":"2021","unstructured":"-Solanki, R., Patel, K. & Patel, S. Bovine serum albumin nanoparticles for the efficient delivery of berberine: Preparation, characterization and in vitro biological studies. Colloids Surf., a. 608, 125501 (2021).","journal-title":"Colloids Surf., a"},{"issue":"7","key":"75116_CR31","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/pharmaceutics13071098","volume":"13","author":"AA -Al-Jubori","year":"2021","unstructured":"-Al-Jubori, A. A. et al. Layer-by-layer nanoparticles of tamoxifen and resveratrol for dual drug delivery system and potential triple-negative breast cancer treatment. Pharmaceutics. 13 (7), 1098 (2021).","journal-title":"Pharmaceutics"},{"issue":"1-2","key":"75116_CR32","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ijpharm.2011.07.036","volume":"419","author":"A Trapani","year":"2011","unstructured":"Trapani, A. et al. Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery. Int. J. Pharm. 419 (1-2), 296\u2013307 (2011).","journal-title":"Int. J. Pharm."},{"key":"75116_CR33","doi-asserted-by":"crossref","unstructured":"Ragusa, A., Priore, P., Giudetti, A. M., Ciccarella, G., & Gaballo, A. (2018). Neuroprotective investigation of chitosan nanoparticles for dopamine delivery. Applied sciences, 8(4),474. Trapani, A., Mandracchia, D., Tripodo, G., Cometa, S., Cellamare, S., De Giglio, E.,\u2026 Antimisiaris, S. G. (2018). Protection of dopamine towards autoxidation reaction by encapsulation into non-coated-or chitosan-or thiolated chitosan-coated-liposomes.Colloids and Surfaces B: Biointerfaces, 170, 11\u201319.","DOI":"10.1016\/j.colsurfb.2018.05.049"},{"issue":"1","key":"75116_CR34","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/10717544.2019.1636420","volume":"26","author":"S Tang","year":"2019","unstructured":"Tang, S. et al. Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson\u2019s disease. Drug Deliv. 26 (1), 700\u2013707 (2019).","journal-title":"Drug Deliv."},{"key":"75116_CR35","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jddst.2018.10.022","volume":"49","author":"S -Naskar","year":"2019","unstructured":"-Naskar, S., Sharma, S. & Kuotsu, K. Chitosan-based nanoparticles: an overview of biomedical applications and its preparation. J. Drug Deliv. Sci. Technol. 49, 66\u201381 (2019).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"75116_CR36","doi-asserted-by":"crossref","unstructured":"Greco, I., Molchanova, N., Holmedal, E., Jenssen, H., Hummel, B. D., Watts, J. L.,\u2026 Svenson, J. (2020). Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides. Scientific reports, 10(1), 13206.","DOI":"10.1038\/s41598-020-69995-9"},{"issue":"45","key":"75116_CR37","doi-asserted-by":"publisher","first-page":"42045","DOI":"10.1021\/acsomega.3c04862","volume":"8","author":"J -Burns","year":"2023","unstructured":"-Burns, J., Buck, A. C., D\u2019Souza, S., Dube, A. & Bardien, S. Nanophytomedicines as therapeutic agents for Parkinson\u2019s Disease. ACS Omega. 8 (45), 42045\u201342061 (2023).","journal-title":"ACS Omega"},{"key":"75116_CR38","doi-asserted-by":"crossref","unstructured":"Liu, Y., Luo, J., Liu, Y., Liu, W., Yu, G., Huang, Y., \u2026 Chen, T. (2022). Brain-targeted biomimetic nanodecoys with neuroprotective effects for precise therapy of Parkinson\u2019s disease. ACS Central Science, 8(9), 1336\u20131349.","DOI":"10.1021\/acscentsci.2c00741"},{"key":"75116_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fbioe.2018.00099","volume":"6","author":"M -Weber","year":"2018","unstructured":"-Weber, M. et al. Blood-contacting biomaterials: in vitro evaluation of the hemocompatibility. Front. Bioeng. Biotechnol. 6, 99 (2018).","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"75116_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11051-023-05921-0","volume":"26","author":"MH Shariare","year":"2024","unstructured":"Shariare, M. H. et al. Phospholipid-based nano drug delivery system of curcumin using MSP1D1 protein and poloxamer 407: a comparative study for targeted drug delivery to the brain. J. Nanopart. Res. 26 (1), 12 (2024).","journal-title":"J. Nanopart. Res."},{"key":"75116_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11051-020-04959-8","volume":"22","author":"N -Maghsoudnia","year":"2020","unstructured":"-Maghsoudnia, N., Eftekhari, R. B., Sohi, A. N., Zamzami, A. & Dorkoosh, F. A. Application of nano-based systems for drug delivery and targeting: a review. J. Nanopart. Res. 22, 1\u201341 (2020).","journal-title":"J. Nanopart. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75116-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75116-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75116-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T10:49:56Z","timestamp":1740566996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75116-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["75116"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75116-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written approval was obtained from the Ethical Approval Committee of the University of Mustansiriyah, Iraq. Study data\/information was used for research purposes only. Informed consent was obtained from each participant. The HINARI (Health Inter Network Access to Research Initiative) programmer, established by WHO together with major publishers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6904"}}